Description

1H-Indazole-1-Acetamide,4,5,6,7-Tetrahydro-n-[3-(1H-Tetrazol-1-Yl)Phenyl]-3-(Trifluoromethyl)-(9Ci) is a high-purity, heterocyclic organic compound featuring a unique molecular scaffold that combines indazole and tetrazole pharmacophores. This complex structure makes it a valuable advanced pharmaceutical intermediate for research and development in medicinal chemistry. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers for the synthesis of novel active pharmaceutical ingredients (APIs).

Application

This specialized chemical serves as a critical building block in several advanced research and manufacturing domains:

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates targeting a range of therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization due to its indazole-tetrazole hybrid structure.
• Biochemical Tool Compound: Employed in biochemical assays and as a probe for studying enzyme inhibition or receptor binding.
• Fine Chemical Synthesis: Serves as a sophisticated starting material or intermediate in multi-step organic syntheses for high-value specialty chemicals.
• Contract Research & Development (CRO/CMO): Supplied to organizations engaged in custom synthesis and process development for client projects.

Basic Information

Product Name	1H-Indazole-1-Acetamide,4,5,6,7-Tetrahydro-n-[3-(1H-Tetrazol-1-Yl)Phenyl]-3-(Trifluoromethyl)-(9Ci)
CAS No.	606096-75-7
Molecular Formula	C18H18F3N7O
Molecular Weight	405.38 g/mol
Synonyms	4,5,6,7-Tetrahydro-1H-indazole-1-acetamide, N-[3-(1H-tetrazol-1-yl)phenyl]-3-(trifluoromethyl)-; 1H-Indazole-1-acetamide, 4,5,6,7-tetrahydro-N-[3-(1H-tetrazol-1-yl)phenyl]-3-(trifluoromethyl)-; 606096-75-7; N-[3-(1H-Tetrazol-1-yl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole-1-acetamide; 3-(Trifluoromethyl)-N-[3-(1H-tetrazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-indazole-1-acetamide
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality management protocols. Every batch undergoes comprehensive analytical characterization to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided, detailing results from HPLC (for assay and purity), 1H/13C NMR, and mass spectrometry. We support cGMP compliance for pharmaceutical applications and can tailor specifications to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to exclude moisture. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.